Avallone A - Search Results

1

Oxaliplatin-Based Chemotherapy in Patients with Metastatic Colorectal Cancer Aged at Least 75 Years: A Post-Hoc Subgroup Analysis of Three Phase II Trials.

Rosati G, Cordio S, Reggiardo G, Aprile G, Butera A, Avallone A, Tucci A, Novello G, Blanco G, Caputo G, Bilancia D, Bordonaro R. Rosati G, et al. Among authors: avallone a. Cancers (Basel). 2019 Apr 24;11(4):578. doi: 10.3390/cancers11040578. Cancers (Basel). 2019. PMID: 31022922 Free PMC article.

2

Cisplatin, raltitrexed, levofolinic acid and 5-fluorouracil in locally advanced or metastatic squamous cell carcinoma of the head and neck: a phase II randomized study.

Caponigro F, Rosati G, De Rosa P, Avallone A, De Rosa V, De Lucia L, Comella P, Comella G. Caponigro F, et al. Among authors: avallone a. Oncology. 2002;63(3):232-8. doi: 10.1159/000065470. Oncology. 2002. PMID: 12381902 Clinical Trial.

3

Discontinuation of bevacizumab and FOLFIRI administered up to a maximum of 12 cycles as first-line therapy for metastatic colorectal cancer: a retrospective Italian study.

Rosati G, Cordio S, Aprile G, Butera A, Avallone A, Di Lucca G, De Pauli F, Parra HS, Reggiardo G, Bordonaro R. Rosati G, et al. Among authors: avallone a. Invest New Drugs. 2012 Oct;30(5):1978-83. doi: 10.1007/s10637-011-9721-6. Epub 2011 Jul 19. Invest New Drugs. 2012. PMID: 21769636 Clinical Trial.

4

XELOX and bevacizumab followed by single-agent bevacizumab as maintenance therapy as first-line treatment in elderly patients with advanced colorectal cancer: the boxe study.

Rosati G, Avallone A, Aprile G, Butera A, Reggiardo G, Bilancia D. Rosati G, et al. Among authors: avallone a. Cancer Chemother Pharmacol. 2013 Jan;71(1):257-64. doi: 10.1007/s00280-012-2004-x. Epub 2012 Oct 26. Cancer Chemother Pharmacol. 2013. PMID: 23100174 Clinical Trial.

5

Bevacizumab and first-line chemotherapy for older patients with advanced colorectal cancer: final results of a Community-based Observational Italian Study.

Lutrino SE, Bergamo F, Schirripa M, Rosati G, Avallone A, Giampieri R, Cordio S, Berretta M, Llimpe FR, Pisa FE, Lonardi S, Loupakis F, Fasola G, Aprile G. Lutrino SE, et al. Among authors: avallone a. Anticancer Res. 2015 Apr;35(4):2391-9. Anticancer Res. 2015. PMID: 25862905 Clinical Trial.

6

A perspective on the current treatment strategies for locally advanced rectal cancer.

Avallone A, Aloj L, Aprile G, Rosati G, Budillon A. Avallone A, et al. Int J Biochem Cell Biol. 2015 Aug;65:192-6. doi: 10.1016/j.biocel.2015.06.002. Epub 2015 Jun 6. Int J Biochem Cell Biol. 2015. PMID: 26055517 Review.

7

Timing and extent of response in colorectal cancer: critical review of current data and implication for future trials.

Aprile G, Fontanella C, Bonotto M, Rihawi K, Lutrino SE, Ferrari L, Casagrande M, Ongaro E, Berretta M, Avallone A, Rosati G, Giuliani F, Fasola G. Aprile G, et al. Among authors: avallone a. Oncotarget. 2015 Oct 6;6(30):28716-30. doi: 10.18632/oncotarget.4747. Oncotarget. 2015. PMID: 26308250 Free PMC article. Review.

8

A randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (Optimization of BEvacizumab scheduLIng within Chemotherapy Scheme).

Avallone A, Piccirillo MC, Aloj L, Nasti G, Delrio P, Izzo F, Di Gennaro E, Tatangelo F, Granata V, Cavalcanti E, Maiolino P, Bianco F, Aprea P, De Bellis M, Pecori B, Rosati G, Carlomagno C, Bertolini A, Gallo C, Romano C, Leone A, Caracò C, de Lutio di Castelguidone E, Daniele G, Catalano O, Botti G, Petrillo A, Romano GM, Iaffaioli VR, Lastoria S, Perrone F, Budillon A. Avallone A, et al. BMC Cancer. 2016 Feb 8;16:69. doi: 10.1186/s12885-016-2102-y. BMC Cancer. 2016. PMID: 26857924 Free PMC article. Clinical Trial.

9

A review and assessment of currently available data of the EGFR antibodies in elderly patients with metastatic colorectal cancer.

Rosati G, Aprile G, Cardellino GG, Avallone A. Rosati G, et al. Among authors: avallone a. J Geriatr Oncol. 2016 Mar;7(2):134-41. doi: 10.1016/j.jgo.2016.01.006. Epub 2016 Feb 18. J Geriatr Oncol. 2016. PMID: 26897044 Review.

10

HER-2 inhibition in gastric and colorectal cancers: tangible achievements, novel acquisitions and future perspectives.

Fanotto V, Ongaro E, Rihawi K, Avallone A, Silvestris N, Fornaro L, Vasile E, Antonuzzo L, Leone F, Rosati G, Giuliani F, Bordonaro R, Scartozzi M, De Maglio G, Negri FV, Fasola G, Aprile G. Fanotto V, et al. Among authors: avallone a. Oncotarget. 2016 Oct 18;7(42):69060-69074. doi: 10.18632/oncotarget.11264. Oncotarget. 2016. PMID: 27542243 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

229 results

Search Page